// App-Quantinova.ai

4590 : Mechanism of PI3K activation by the HER3/ErbB3 receptor

Researchers

Presenter

  • Nicole Michael

Principal Investigators

  • Michael Hopkins

  • Natalia Jura

Medical Centers

  • University of California, San Francisco, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Hepatocyte growth factor receptor

  • Epidermal growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

  • Erb-B2 Receptor Tyrosine Kinase 3

  • Human epidermal growth factor receptor 3

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved